Last Updated: November 9, 2026

Patent: 11,406,945

Summary for Patent: 11,406,945

Title:	Device, system and method for mixing
Abstract:	A device or system includes a mixer comprising a three-dimensional lattice defining a plurality of tortuous, interconnecting passages therethrough. The mixer is in communication with sources or streams of at least two separate components which, when mixed, form a combined fluid stream. The sources or streams may be, at least initially, on opposite sides of the mixer, or the sources or streams may be on the upstream side of the mixer with an outlet disposed downstream of the mixer. A related method may include providing a mixer comprising a three-dimensional lattice defining a plurality of tortuous, interconnecting passages therethrough, and selecting a material for the mixer based on physical characteristics of said material, said characteristics including a selected one or more of mean flow pore size, thickness and porosity volume.
Inventor(s):	Yves A. Delmotte
Assignee:	Baxter Healthcare SA , Baxter International Inc
Application Number:	US15/457,802
Patent Claims:	see list of patent claims

Details for Patent 11,406,945

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Baxter Healthcare Corporation	ARTISS	fibrin sealant (human)	Solution	125266	March 19, 2008	11,406,945	2037-03-13
Baxter Healthcare Corporation	ARTISS	fibrin sealant (human)	For Solution	125266	March 19, 2008	11,406,945	2037-03-13
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,406,945

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Austria	E473693	⤷ Start Trial
Australia	2007205932	⤷ Start Trial
Brazil	PI0706629	⤷ Start Trial
Canada	2632608	⤷ Start Trial
China	101370433	⤷ Start Trial
China	102631226	⤷ Start Trial
Germany	602007007725	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.